Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05662306 · ClinicalTrials.gov registry record · Phase 4
C-Cog in Early Course Schizophrenia Study
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT05662306 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 1 participants.
The verdict
NCT05662306, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.
Interventions
- DRUG Aripiprazole Lauroxil
- BEHAVIORAL Computerized cognitive and functional skills training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-01-23 |
| Est. Completion | 2025-03-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05662306
The ClinicalTrials.gov registry entry for NCT05662306 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aripiprazole Lauroxil is the first listed.
NCT05662306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05662306 about?
NCT05662306 is a clinical study titled "C-Cog in Early Course Schizophrenia Study". The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.
What is the current status of trial NCT05662306?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2024-01-23. Estimated completion is 2025-03-03.
What interventions are being tested in trial NCT05662306?
The interventions under investigation include: Aripiprazole Lauroxil (DRUG), Computerized cognitive and functional skills training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05662306?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.